Lying Is Wrong—Unless You Work In Tobacco Control

The anti-vaping crusade has produced awful science and dishonest, vitriolic attacks on a nascent industry that is helping millions of people quit smoking. Case in point: the authors of a November 2022 study accused vaping company JUUL of altering the menthol content of one of its products to skirt Food and Drug Administration (FDA) regulation. Not only was the accusation false, the study authors knew it was false and published the paper anyway.

Brief background: In February 2020, the FDA banned all flavored, pod-based vapes, excluding tobacco and menthol. The study alleged that JUUL altered its menthol product to end-run the effects of the agency’s new flavor rule. This was a very serious allegation, as tobacco-control expert Clive Bates explained in a recent blog post:

… [F]or a vaping company to change the formulation of its products at the time would have been illegal and opened it up to enforcement action that could have removed some or all of its products from the market … [T]hey were not allowed to modify their products unless and until [an FDA authorization application] for the modified product had been successful.

The study very well could have swayed the FDA’s decision to deny marketing authorization for JUUL’s products. This is doubly so because the study was “supported by … the Center for Tobacco Products of the US Food and Drug Administration,” the regulatory authority tasked with reviewing the product in question. The bigger problem is that the company’s customers could have been left without access to the technology that helped them quit smoking.

There were numerous problems with the accusation. First, the researchers confused “the evaporation of the volatile menthol flavoring agent with a deliberate product modification,” Bates noted. The former is a well-known occurrence during storage; the latter is blatantly illegal. JUUL explained this to the researchers months before they published their study, then said the same publicly after the paper appeared online:

“The implications made about JUUL products in this study are contradicted by our own contemporaneous and detailed product and manufacturing records and are more readily explained by a methodological artifact that the authors have not fully reported, even after a direct prompt before submitting the manuscript.”

For almost six months, neither the study authors nor the journal that published their analysis responded to JUUL’s criticism. The text of the study was finally updated in April 2023 as follows:

Original: In conclusion, our findings suggest the possibility that the menthol content of JUUL pods changed in a manner that may have increased the appeal of these products when other flavoured pod-based products were no longer available. This work highlights the need to consider the menthol and other natural and synthetic coolants in e-cigarettes as a possible target for regulation, as well as the need for regular independent testing to assure that products remain compliant with regulation.

Revised: This study shows that concentrations of nicotine and menthol in JUUL products procured over a 3 year period decreased over time, possibly due to product degradation during storage. The findings highlight challenges of reconstructing product characteristics at the time of manufacture and time of consumption and suggests the utility of an ENDS product bank that could preserve samples for retrospective studies.

Did the authors apologize for making such an outrageous accusation? No. AVM’s Greg Conley filed a freedom of information request with the school that employs the study authors. “No author expressed an ounce of sympathy or embarrassment,” he observed after reviewing the researchers’ email exchanges about the study.

It actually gets worse. The authors not only refused to apologize, they doubled down. “Given the [tobacco] industry‘s long history of industry obfuscation, interference, and deception regarding research on tobacco products,” they wrote in response to JUUL’s criticism, “we decided … to report our results independently and respond to any public discussion of our work if and when it arose.”

Like the flawed studies I’ve discussed in past columns, this example sadly illustrates just how far tobacco control has fallen. Not only is junk science tolerated in this field, apparently so is outright deception—as long as your work is critical of e-cigarettes.

This sad state of affairs prompts an important question: if these scientists want smokers to quit, why do they dishonestly attack vaping, the most effective cessation tool that’s ever been developed? They’re either oblivious to the fact that they’re encouraging smokers to keep smoking, or they know and don’t care. Neither answer is acceptable.

Recent Articles

I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.
State-sanctioned medical and recreational cannabis programs benefit the average user in many ways. Still, they remain a double-edged sword for dispensary owners, greenhouse growers, and others who earn their living from the cannabis industry. There are plenty of profits to be had, sure, but how exactly are you expected to secure your cash or process electronic transactions when banks refuse to work with you?
Aubrey Amatelli wants to help dispensaries and cannabis retailers navigate one of the toughest parts of the industry: money. When the company she worked for right out of grad school was acquired by JPMorgan, Aubrey entered the complex world of payments and has stayed there for her entire career.
There’s a paradox to business conferences. The best ones manage to swing from buttoned down to wildly unscripted—sometimes seconds apart. For attendees, it’s the combination of personal connections and professional development that makes regular trips to conferences worthwhile. And in an industry like this one, pulling that off is harder than it looks.
Your shop is not only a smoke shop; It's also a hangout spot and a community hub. It is a place where the regulars know your staff by name, and your staff knows what the regulars need. That's the secret sauce that the big-box chains can't replicate, and it starts with who you put behind the counter. A well-staffed smoke shop is an operational strategy, but it's also a community. In lean economic times, that community is what keeps the lights on. When people feel like your shop is their spot, they don't stop coming in when money's tight. They prioritize it. It all starts with Hiring.
Dr. Macias first fell in love with science while studying at Howard University, where she completed her undergraduate studies and later earned her PhD in cellular and molecular biology. While at Howard, she became especially interested in cancer research due to personal ties. Growing up in a Creole family and predominantly Black community in Louisiana, Dr. Macias watched many women around her battle breast cancer, so at Howard, she decided to focus her research on the BRCA1 gene.
It’s almost amazing that the same institutions that brought us the 2008 financial crisis have a problem with selling glass pipes. Almost. The truth is that an industry's past sins are only held against it when the money isn’t right. Big banks were willing to risk cratering the U.S. housing market because the profits were too good to ignore. But the cannabis industry rolls a different kind of paper, so instead of a slap on the wrist, it gets a surcharge.
Smokeshop and counterculture enthusiasts enjoy discovery as part of the experience. Customers enjoy browsing. When they walk into a shop, they don't simply grab a product and leave. They look for something new. This is the main reason flyers and posters still work. Smokeshops and dispensaries are highly visual environments. You want to see bold artwork, psychedelic graphics, and street-style posters that naturally capture attention.